Florida Financial Advisors LLC Raises Position in Cardinal Health, Inc. $CAH

Florida Financial Advisors LLC increased its stake in Cardinal Health, Inc. (NYSE:CAH) by 21.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 15,203 shares of the company’s stock after buying an additional 2,643 shares during the quarter. Cardinal Health comprises 0.8% of Florida Financial Advisors LLC’s portfolio, making the stock its 28th largest position. Florida Financial Advisors LLC’s holdings in Cardinal Health were worth $3,213,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of CAH. Integrated Wealth Concepts LLC raised its stake in shares of Cardinal Health by 6.9% during the first quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after purchasing an additional 280 shares during the period. Jones Financial Companies Lllp boosted its stake in shares of Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership acquired a new stake in Cardinal Health during the 2nd quarter valued at $1,935,000. Cerity Partners LLC grew its holdings in Cardinal Health by 17.0% during the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock valued at $6,792,000 after purchasing an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC increased its stake in Cardinal Health by 34.4% during the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after buying an additional 2,646 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 1.2%

Shares of CAH opened at $225.76 on Tuesday. The firm has a market cap of $52.88 billion, a price-to-earnings ratio of 34.52, a PEG ratio of 1.12 and a beta of 0.49. The stock has a 50 day moving average of $217.11 and a 200-day moving average of $213.94. Cardinal Health, Inc. has a 52 week low of $137.75 and a 52 week high of $243.21.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the previous year, the business earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 10.77 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st were issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend was Wednesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.50%.

Analyst Ratings Changes

CAH has been the topic of a number of recent analyst reports. Zacks Research lowered shares of Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. JPMorgan Chase & Co. dropped their target price on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Robert W. Baird set a $248.00 price target on Cardinal Health in a report on Friday, May 1st. Wells Fargo & Company lowered their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Finally, Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $250.07.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.